Vaccines based on replication-defective adenoviral vectors are being developed for infectious agents and tumor-associated antigens. Early work focused on vaccines derived from a common human serotype ...

Forbes contributors publish independent expert analyses and insights. Dr. Lance B. Eliot is a world-renowned AI scientist and consultant. In today’s column, I examine the underlying mechanisms that ...

In an NBC News story about the reality gap between businesses talking about artificial intelligence (AI) and those that are actually using it, an investment analyst from Oppenheimer said, “There’s not ...

Viral vectors dominate gene therapy, with lentivirus, adenovirus, and AAV being key players, each with unique advantages and limitations. Non-viral vectors, such as lipid nanoparticles and GalNAc, ...

Despite the aggressive cost claims and dramatic scale improvements, AWS is positioning S3 Vectors as a complementary storage tier rather than a direct replacement for specialized vector databases.